Tracing the origins of "fetal origins" of adult diseases: Programming by oxidative stress?

Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada
Medical Hypotheses (Impact Factor: 1.15). 02/2006; 66(1):38-44. DOI: 10.1016/j.mehy.2005.08.020
Source: PubMed

ABSTRACT Too small size at birth (due to poor fetal growth and/or preterm delivery) has been associated with substantially elevated risks of the metabolic syndrome (dislipidemia, insulin resistance, hypertension), type 2 diabetes and cardiovascular disease in adulthood. The mechanisms of such "fetal origins" or "programming" of disease phenomenon remain unresolved. Too large size at birth seems also associated with an increased risk. Many known or suspected causes of or conditions associated with adverse (poor or excessive) fetal growth or preterm birth have been associated with oxidative stress. Plausibly, oxidative stress may be a common link underlying the superficial "programming" associations between adverse fetal growth or preterm birth and elevated risks of certain chronic diseases. The mechanisms of oxidative stress programming may be through directly modulating gene expression or indirectly through the effects of certain oxidized molecules. Experimental investigations have well demonstrated the role of redox balance in modulating gene expression, and recent studies indicate that both the insulin functional axis and blood pressure could be sensitive targets to oxidative stress programming. Adverse programming may occur without affecting fetal growth, but more frequently among low birth weight infants merely because they more frequently experienced known or unknown conditions with oxidative insults. As oxidative stress levels are easily modifiable during pregnancy and early postnatal periods (which are plausible critical windows), the hypothesis, if proved valid, will suggest new measures that could be very helpful on fighting the increasing epidemic of the metabolic syndrome, type 2 diabetes and cardiovascular disease. Currently, there are several ongoing large randomized trials of antioxidant supplementation to counter oxidative stress during pregnancy for the prevention of preeclampsia. It would be invaluable if long-term follow-ups of infants born to women in such trials could be realized to test the oxidative stress programming hypothesis in such experimental trial settings.

Download full-text


Available from: Zhong-Cheng Luo, Jul 03, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The placenta is the exchange organ that regulates metabolic processes between the mother and her developing fetus. The adequate function of this organ is clearly vital for a physiologic gestational process and a healthy baby as final outcome. The umbilico-placental vasculature has the capacity to respond to variations in the materno-fetal milieu. Depending on the intensity and the extensity of the insult, these responses may be immediate-, mediate-, and long-lasting, deriving in potential morphostructural and functional changes later in life. These adjustments usually compensate the initial insults, but occasionally may switch to long-lasting remodeling and dysfunctional processes, arising maladaptation. One of the most challenging conditions in modern perinatology is hypoxia and oxidative stress during development, both disorders occurring in high-altitude and in low-altitude placental insufficiency. Hypoxia and oxidative stress may induce endothelial dysfunction and thus, reduction in the perfusion of the placenta and restriction in the fetal growth and development. This Review will focus on placental responses to hypoxic conditions, usually related with high-altitude and placental insufficiency, deriving in oxidative stress and vascular disorders, altering fetal and maternal health. Although day-to-day clinical practice, basic and clinical research are clearly providing evidence of the severe impact of oxygen deficiency and oxidative stress establishment during pregnancy, further research on umbilical and placental vascular function under these conditions is badly needed to clarify the myriad of questions still unsettled.
    Frontiers in Pharmacology 06/2014; 5:149. DOI:10.3389/fphar.2014.00149
  • Source
    Basic and Clinical Endocrinology Up-to-Date, 10/2011; , ISBN: 978-953-307-340-8
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationship between season of birth and various physical and psychological outcomes was reported in many studies, although the underlying mechanism still remains unrecognized. The aim of this study was to explore the season-of-birth effect on body size in the sample of 1,148 eight-year-old Polish urban children and propose the mechanism responsible for this effect. The children were examined three times at their birthdays and at two cross-sectional surveys. Effects of the season of birth were checked by fitting the cosine function to empirical values and by comparison between two groups born in different periods of the year. Data gathered at three examinations led to the same results: season-of-birth effect occurred only in boys and only in those relatively shortly breastfed and/or descended from the families of low-socioeconomic status. Specifically, the individuals born in October-April were taller (by 2-3 cm), heavier (by 2-3 kg), and fatter than those born in May-September. The following explanatory mechanism has been formulated: insolation in Poland is minimal in November-February (winter period), and so ultraviolet absorption and vitamin D production is then the lowest. Vitamin D regulates embryo's cellular differentiation, and its deficiency triggers permanent developmental changes. Therefore, individuals conceived in autumn (i) are at the greatest risk of early vitamin D deficiency, (ii) are born in summer, and (iii) are relatively small in their further lives. The contribution of low-socioeconomic status, short breastfeeding, and being a male to the occurrence of the season-of-birth effect is also discussed.
    American Journal of Human Biology 03/2011; 23(2):190-200. DOI:10.1002/ajhb.21101 · 1.93 Impact Factor